![Simba Gill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simba Gill
Directeur/Membre du Conseil chez
FOGHORN THERAPEUTICS INC.
Fortune : 145 781 $ au 31/05/2026
Profil
Balkrishan Gill was the founder of Moksha8 Pharmaceuticals, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2006 to 2015.
Current jobs include Executive Co-Chairman at Serina Therapeutics, Inc. starting in 2026, Independent Director at Foghorn Therapeutics, Inc. since 2017, and Director at Sensorium Therapeutics, Inc. Former jobs include President, Chief Executive Officer & Director at Evelo Biosciences, Inc. from 2022 to 2023, Chairman at Blackfynn, Inc., Director at Codexis, Inc., Director at Realm Therapeutics Plc from 2016 to 2019, Marketing Director at Roche Diagnostics GmbH, President & Chief Financial Officer at Maxygen, Inc. from 1997 to 2013, Venture Partner at TPG Growth LLC, Scientist at Celltech Ltd., Head-Corporate Development at Systemix, Inc., Head-Corporate Development at Valentis, Inc., and Partner at Flagship Pioneering, LLC.
Education includes an MBA from INSEAD and a doctorate from King's College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 34 061 ( 0,06 % ) | 145 781 $ | 31/05/2026 |
Postes actifs de Simba Gill
| Sociétés | Poste | Début |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/07/2017 |
Sensorium Therapeutics, Inc.
 Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for mental illness | Directeur/Membre du Conseil | - |
Anciens postes connus de Simba Gill
| Sociétés | Poste | Fin |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Directeur Général | 20/11/2023 |
| REALM THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/01/2019 |
Moksha8 Pharmaceuticals, Inc.
 Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Fondateur | 01/01/2015 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Directeur Financier/CFO | 27/11/2013 |
TPG Growth LLC
 TPG Growth LLC Investment ManagersFinance TPG Growth invests in middle-market companies located in the United States, Asia and other selected united regions. The firm focuses on a broad range of sectors and industries. It provides financing for growth and buyouts capital requirements. | Private Equity Investor | 30/11/2007 |
Formation de Simba Gill
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Moksha8 Pharmaceuticals, Inc.
Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics | Commercial Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth invests in middle-market companies located in the United States, Asia and other selected united regions. The firm focuses on a broad range of sectors and industries. It provides financing for growth and buyouts capital requirements. | Finance |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural science and engineering | Commercial Services |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Blackfynn, Inc.
 Blackfynn, Inc. Internet Software/ServicesTechnology Services Operates as cloud-based data management and integration solutions for researchers, research teams and enterprises | Technology Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Sensorium Therapeutics, Inc.
Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for mental illness | Health Technology |
